About the Ozempic Lawsuit

Ozempic is a drug that has received approval from the Food and Drug Administration (FDA) to lower blood sugar levels in adults suffering from type 2 diabetes.

Recently, it has gained popularity as a weight loss supplement.

Wegovy, another FDA-approved medication, is primarily prescribed for chronic weight management in adults who are obese.

Ozempic and Mounjaro both use the active ingredient semaglutide.

There are concerns that these medications, or their compounded variations, may be associated with severe gastroparesis, also known as “stomach paralysis”.

Other potential health concerns linked to these drugs include gallbladder disease and cyclic vomiting syndrome, among other serious medical conditions.

Gastroparesis, also known as stomach paralysis, is a medical condition that affects the gastrointestinal nerves and muscles in the stomach.

This disrupts the process of food transportation from the stomach to the small intestine.

The symptoms and side effects of severe gastrointestinal events and complications (like gastroparesis) can cause discomfort and pain, potentially leading to serious health issues.

Gallbladder disease encompasses conditions such as gallstones and cholecystitis, which is inflammation of the gallbladder.

These conditions can cause discomfort and may necessitate the removal of the gallbladder.

There is currently an investigation into legal action relating to these symptoms and injuries.

If you or a family member has used Ozempic, Wegovy, Mounjaro, or any compound versions of these drugs, and subsequently developed gallbladder disease, gastroparesis, cyclic vomiting syndrome, or any other related health complications, you may be eligible to file a lawsuit claim involving Ozempic.

Keith’s Law Group is available for a free consultation.

You can also utilize the chatbot on the page for immediate evaluation of your case.